pubmed-article:10233192 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C0028978 | lld:lifeskim |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C0034665 | lld:lifeskim |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C0686904 | lld:lifeskim |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C2348070 | lld:lifeskim |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C0521112 | lld:lifeskim |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C0240526 | lld:lifeskim |
pubmed-article:10233192 | lifeskim:mentions | umls-concept:C1168023 | lld:lifeskim |
pubmed-article:10233192 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:10233192 | pubmed:dateCreated | 1999-6-10 | lld:pubmed |
pubmed-article:10233192 | pubmed:abstractText | We have previously shown that 70% of patients experience nocturnal gastric acid breakthrough (defined as pH<4 for more than 60 min between 22.00 and 06.00 hours) on twice a day (b.d.) proton pump inhibitor. Adding 150 or 300 mg of ranitidine at bedtime is more effective than additional omeprazole at bedtime in control of night-time acid breakthrough. | lld:pubmed |
pubmed-article:10233192 | pubmed:language | eng | lld:pubmed |
pubmed-article:10233192 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10233192 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10233192 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10233192 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10233192 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10233192 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10233192 | pubmed:month | May | lld:pubmed |
pubmed-article:10233192 | pubmed:issn | 0269-2813 | lld:pubmed |
pubmed-article:10233192 | pubmed:author | pubmed-author:CastellD ODO | lld:pubmed |
pubmed-article:10233192 | pubmed:author | pubmed-author:KhouryR MRM | lld:pubmed |
pubmed-article:10233192 | pubmed:author | pubmed-author:KatzP OPO | lld:pubmed |
pubmed-article:10233192 | pubmed:author | pubmed-author:HammonDD | lld:pubmed |
pubmed-article:10233192 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10233192 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:10233192 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10233192 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10233192 | pubmed:pagination | 675-8 | lld:pubmed |
pubmed-article:10233192 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:meshHeading | pubmed-meshheading:10233192... | lld:pubmed |
pubmed-article:10233192 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10233192 | pubmed:articleTitle | Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. | lld:pubmed |
pubmed-article:10233192 | pubmed:affiliation | Department of Medicine, The Graduate Hospital, Philadelphia, Pennsylvania 19146, USA. | lld:pubmed |
pubmed-article:10233192 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10233192 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10233192 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:10233192 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10233192 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10233192 | lld:pubmed |